Severity
Moderate
FDA Devices recall · Reported March 11, 2020
There is the potential presence of particular matter in the header caps of ten lots the Revaclear 300 Dialyzer.
Baxter Healthcare Corporation recalled Revaclear Capillary Dialyzer 300, REF Revaclear 300 Product Code 114745L - a moderate-severity action.
Revaclear Capillary Dialyzer 300, REF Revaclear 300 Product Code 114745L was recalled by Baxter Healthcare Corporation in March 11, 2020. Reason: There is the potential presence of particular matter in the header caps of ten lots the Revaclear 300 Dialyze…. Check the official notice for the remedy. Verify recall #Z-1409-2020 with the FDA Devices before acting.
The recall
Baxter Healthcare Corporation issued this moderate-severity FDA Devices recall-There is the potential presence of particular matter in the header caps of ten lots the Revaclear 300 Dialyze….
Sourced from official FDA Devices enforcement records. Verify recall #Z-1409-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-1409-2020) was formally reported on March 11, 2020, with the manufacturer initiating the action on November 15, 2019. It is classified under Moderate severity (Class II), with a current status of Terminated. Baxter Healthcare Corporation is listed as the recalling firm, operating out of Deerfield, IL. Federal records list the affected scope as 101976 devices, a scale large enough to require multi-state distribution tracking.
The documented reason for this recall is: There is the potential presence of particular matter in the header caps of ten lots the Revaclear 300 Dialyzer. Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
101976 devices
Related Recalls
6
3 from same agency
Revaclear Capillary Dialyzer 300, REF Revaclear 300 Product Code 114745L
There is the potential presence of particular matter in the header caps of ten lots the Revaclear 300 Dialyzer.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-1409-2020 |
| Date reported | March 11, 2020 |
| Date initiated | November 15, 2019 |
| Recalling firm | Baxter Healthcare Corporation |
| Firm location | Deerfield, IL |
| Affected scope | 101976 devices |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported March 11, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.